Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Musher

Showing results (31-40 of 183) with videos related to

Pageof 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremiaMark Parta, Daniel M Musher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2012
Diagnosis of Clostridium difficile infectionDaniel M Musher, Charles Stager
Open Forum Infectious Diseases|July 7, 2022
The White Blood Cell Response in Sputum in Viral and Bacterial PneumoniasSaeed Shoar, Daniel M Musher
The Australasian Medical Journal|August 1, 2012
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?Iman Ridda, Daniel M Musher
Critical Care Clinics|March 26, 2008
Treatment of clostridium difficile colitis in the critical care settingDaniel M Musher, Saima Aslam
Evidence-Based Medicine|January 15, 2016
Non-toxigenic Clostridium difficile to prevent recurrent C. difficile infectionDaniel M Musher, Hoonmo Koo
Pneumonia (Nathan Qld.)|October 7, 2020
Etiology of community-acquired pneumonia in adults: a systematic reviewSaeed Shoar, Daniel M Musher
Gastroenterology Clinics of North America|August 2, 2006
An update on diagnosis, treatment, and prevention of Clostridium difficile-associated diseaseSaima Aslam, Daniel M Musher
JAMA|May 6, 2010
Preventing myocardial infarction with vaccination: myths and realitiesMohammad Madjid, Daniel M Musher
Future Microbiology|November 29, 2007
Nitazoxanide: clinical studies of a broad-spectrum anti-infective agentSaima Aslam, Daniel M Musher
Pageof 19

Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremiaMark Parta, Daniel M Musher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2012
Diagnosis of Clostridium difficile infectionDaniel M Musher, Charles Stager
Open Forum Infectious Diseases|July 7, 2022
The White Blood Cell Response in Sputum in Viral and Bacterial PneumoniasSaeed Shoar, Daniel M Musher
The Australasian Medical Journal|August 1, 2012
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?Iman Ridda, Daniel M Musher
Critical Care Clinics|March 26, 2008
Treatment of clostridium difficile colitis in the critical care settingDaniel M Musher, Saima Aslam
Evidence-Based Medicine|January 15, 2016
Non-toxigenic Clostridium difficile to prevent recurrent C. difficile infectionDaniel M Musher, Hoonmo Koo
Pneumonia (Nathan Qld.)|October 7, 2020
Etiology of community-acquired pneumonia in adults: a systematic reviewSaeed Shoar, Daniel M Musher
Gastroenterology Clinics of North America|August 2, 2006
An update on diagnosis, treatment, and prevention of Clostridium difficile-associated diseaseSaima Aslam, Daniel M Musher
JAMA|May 6, 2010
Preventing myocardial infarction with vaccination: myths and realitiesMohammad Madjid, Daniel M Musher
Future Microbiology|November 29, 2007
Nitazoxanide: clinical studies of a broad-spectrum anti-infective agentSaima Aslam, Daniel M Musher
Pageof 19